0

Journal Articles

in Health Promotion/Disease Prevention
 121-140 of 264 Articles
From the Centers for Disease Control and Prevention |  June 24, 2009 FREE
Pool Chemical–Associated Health Events in Public and Residential Settings—United States, 1983-2007
JAMA. 2009;301(24):2543-2545. doi:.
Editorial |  June 03, 2009
Health Promotion and Disease Prevention in Children:  It's Never Too Early
Jody W. Zylke, MD; Catherine D. DeAngelis, MD, MPH
JAMA. 2009;301(21):2270-2271. doi:10.1001/jama.281.16.1544.
Special Communication |  June 03, 2009
Neuroscience, Molecular Biology, and the Childhood Roots of Health Disparities:  Building a New Framework for Health Promotion and Disease Prevention
Jack P. Shonkoff, MD; W. Thomas Boyce, MD; Bruce S. McEwen, PhD
JAMA. 2009;301(21):2252-2259. doi:10.1001/jama.2009.754.
Original Contribution |  May 27, 2009 FREE
Prevalence of Cardiovascular Disease Risk Factors Among National Football League Players
Andrew M. Tucker, MD; Robert A. Vogel, MD; Andrew E. Lincoln, ScD; et al.
JAMA. 2009;301(20):2111-2119. doi:10.1001/jama.2009.716.
Medical News & Perspectives |  May 20, 2009
Researchers Argue Imaging Has Role in Assessing Cardiovascular Disease Risk
Mike Mitka
JAMA. 2009;301(19):1973-1974. doi:10.1001/jama.2009.670.
Commentary |  May 13, 2009
Grow the US National Health Service Corps
Jonathan F. Saxton, JD; Michael M. E. Johns, MD
JAMA. 2009;301(18):1925-1926. doi:10.1001/jama.2009.660.
Editorial |  May 13, 2009
Aspirin and Secondary Prevention in Peripheral Artery Disease:  A Perspective for the Early 21st Century
Mary McGrae McDermott, MD; Michael H. Criqui, MD, MPH
JAMA. 2009;301(18):1927-1928. doi:10.1001/jama.2009.668.
Health Agencies Update |  April 22, 2009
New Aspirin Recommendations
Bridget M. Kuehn
JAMA. 2009;301(16):1647. doi:10.1001/jama.2009.539.
From the Centers for Disease Control and Prevention |  April 01, 2009 FREE
Motor Vehicle–Related Death Rates—United States, 1999-2005
JAMA. 2009;301(13):1333-1334. doi:.
Commentary |  February 04, 2009
A Closer Look at the Economic Argument for Disease Prevention
Steven H. Woolf, MD, MPH
JAMA. 2009;301(5):536-538. doi:10.1001/jama.2009.51.
Commentary |  December 10, 2008
Socioeconomic Status and Coronary Heart Disease Risk Prediction
Kevin Fiscella, MD, MPH; Daniel Tancredi, PhD
JAMA. 2008;300(22):2666-2668. doi:10.1001/jama.2008.792.
Medical News & Perspectives |  December 10, 2008
Preventive Services Task Force Endorses Breastfeeding Support in Primary Care
Bridget M. Kuehn
JAMA. 2008;300(22):2598. doi:10.1001/jama.2008.713.
Commentary |  December 03, 2008
Male Circumcision as an HIV Prevention Strategy in Sub-Saharan Africa:  Sociolegal Barriers
Lawrence O. Gostin, JD; Catherine A. Hankins, MD, MSc, FRCPC
JAMA. 2008;300(21):2539-2541. doi:10.1001/jama.2008.752.
Editorial |  November 12, 2008
Aspirin for Primary Prevention of Cardiovascular Events in Diabetes:  Still an Open Question
Antonio Nicolucci, MD
JAMA. 2008;300(18):2180-2181. doi:10.1001/jama.2008.625.
Original Contribution |  November 12, 2008 FREE
Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes:  A Randomized Controlled Trial
Hisao Ogawa, MD, PhD; Masafumi Nakayama, MD, PhD; Takeshi Morimoto, MD, PhD; et al.
JAMA. 2008;300(18):2134-2141. doi:10.1001/jama.2008.623.
Commentary |  October 15, 2008
Transforming Research Strategies for Understanding and Preventing Obesity
Terry T.-K. Huang, PhD, MPH; Thomas A. Glass, PhD
JAMA. 2008;300(15):1811-1813. doi:10.1001/jama.300.15.1811.
Editorial |  October 08, 2008
Circumcision and HIV Prevention Among Men Who Have Sex With Men:  No Final Word
Sten H. Vermund, MD, PhD; Han-Zhu Qian, MD, PhD
JAMA. 2008;300(14):1698-1700. doi:10.1001/jama.300.14.1698.
Research Letters |  October 01, 2008 FREE
Driving Fatalities on US Presidential Election Days
Donald A. Redelmeier, MD, MSHSR; Robert J. Tibshirani, PhD
JAMA. 2008;300(13):1518-1520. doi:10.1001/jama.300.13.1518.
JAMA Classics |  September 17, 2008 FREE
The Multiple Risk Factor Intervention Trial (MRFIT)—Importance Then and Now
Jeremiah Stamler, MD; James D. Neaton, PhD
JAMA. 2008;300(11):1343-1345. doi:10.1001/jama.300.11.1343.
INCLUDES: , Supplemental Content
Commentary |  July 23, 2008
Obesity Prevention in the Information Age:  Caloric Information at the Point of Purchase
JAMA. 2008;300(4):433-435. doi:10.1001/jama.300.4.433.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
RESEARCH LETTER  |  June 17, 2013
ω-3 Fatty Acid Supplements for Secondary Prevention of Cardiovascular Disease: From “No Proof of Effectiveness” to “Proof of No Effectiveness”
Andrea Messori, PharmD; Valeria Fadda, PharmD; Dario Maratea, PharmD; et al.
JAMA Internal Medicine
Editor's Correspondence  |  June 10, 2013
Noncommunicable Diseases in Developing Countries: Focus on Research Capacity Building
Ayodele Odutayo, BHSc; Naheed Hirji, BASc
JAMA Pediatrics
Correction  |  June 01, 2013
Omission in eTable in: Prevention of Adult Obesity: How Much Weight Change Is Necessary for Normalization of Weight Status in Children?
JAMA Internal Medicine
Research Letters  |  May 13, 2013
Rapid Assessment of Cardiovascular Risk Among Users of Smoking Cessation Drugs Within the US Food and Drug Administration's Mini-Sentinel Program
Sengwee Toh, ScD; Meghan A. Baker, MD, ScD; Jeffrey S. Brown, PhD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems